Calcineurin inhibitors in the treatment of cutaneous infantile haemangiomas: LETTER to the EDITOR

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 5, 2010, Pages 614-615

  Lazaridou, E ^a   Giannopoulou, C ^a   Apalla, Z ^a   Fotiadou, C ^a   Tsorova, C ^a   Ioannides, D ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PIMECROLIMUS; STEROID; TACROLIMUS; CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEMANGIOMA; HUMAN; INFANT; INFANTILE HEMANGIOMA; LETTER; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN EXAMINATION; SKIN HEMANGIOMA; ANALOGS AND DERIVATIVES; IMMUNOLOGY; SKIN NEOPLASMS;

CALCINEURIN INHIBITORS; CHILD, PRESCHOOL; FEMALE; HEMANGIOMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; SKIN NEOPLASMS; TACROLIMUS;

EID: 77950856740     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03454.x     Document Type: Letter

References (7)

1. Sun ZJ, Zhao YF, Zhang WF. Immune response: a possible role in the pathophysiology of hemangioma. Med Hypotheses 2007 68 : 353 355. (Pubitemid 44879804)
2. Jia J, Zhao YF, Zhao JH. Potential roles of allograft inflammatory factor-1 in the pathogenesis of hemangiomas. Med Hypotheses 2007 68 : 288 290. (Pubitemid 44879823)
3. Hazen PG, Carney JF, Engstrom CW et al. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream. Pediatr Dermatol 2005 22 : 254 256. (Pubitemid 40741266)
4. Ho NT, Lansang P, Pope E. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol 2007 56 : 63 68. (Pubitemid 46016997)
5. Barry RB, Hughes BR, Cook LJ. Involution of infantile haemangiomas after imiquimod 5% cream. Clin Exp Dermatol 2008 33 : 446 449.
6. Chan B, Greenan G, McKeon F, Ellenberger T. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci USA 2005 102 : 13075 13080. (Pubitemid 41324981)
7. Gollogly LK, Ryeom SW, Yoon SS. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR on calcineurin signaling in endothelial cells and inhibits angiogenesis. J Surg Res 2007 142 : 129 136.